Stereotaxis (STXS) Capital Expenditures (2010 - 2026)
Stereotaxis (STXS) posted quarterly Capital Expenditures of $79000.0 for Q1 2026, up 243.48% year-over-year from $23000.0 in Q1 2025, and up 12.86% quarter-over-quarter from $70000.0 in Q4 2025.
Stereotaxis (STXS) Capital Expenditures (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Capital Expenditures for 14 consecutive years, with $79000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Capital Expenditures rose 243.48% year-over-year to $79000.0; the TTM figure through Mar 2026 stood at $149000.0 (up 325.71% YoY), while the FY2025 annual figure was $93000.0, up 173.53% from the prior year.
- Capital Expenditures rose to $79000.0 in Q1 2026 per STXS's latest filing, from $70000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.2 million in Q1 2022 and bottomed at $2000.0 in Q4 2024.
- Historically, Capital Expenditures has averaged $244000.0 across 5 years, with a median of $74500.0 in 2025.
- Annual changes were most pronounced in 2023 — Capital Expenditures sank 98.92% — and 2025, when it surged 3400.0%.
- Stereotaxis' Capital Expenditures stood at $369000.0 in 2022, then slumped by 97.29% to $10000.0 in 2023, then tumbled by 80.0% to $2000.0 in 2024, then soared by 3400.0% to $70000.0 in 2025, then increased by 12.86% to $79000.0 in 2026.
- Business Quant data shows STXS's Capital Expenditures at $79000.0 in Q1 2026, $70000.0 in Q4 2025, and $23000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Stereotaxis | 141.91 Mn | 127.29 Mn | 3.79 Mn | 79,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -30,000.00 |
| Jun 30, 2026 | -30,000.00 |
| Mar 31, 2026 | 79,000.00 |
| Mar 31, 2026 | 79,000.00 |
| Dec 31, 2025 | 70,000.00 |
| Dec 31, 2025 | 70,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Mar 31, 2025 | 23,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Sep 30, 2023 | 10,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 349,000.00 |
| Mar 31, 2023 | 349,000.00 |
| Dec 31, 2022 | 369,000.00 |
| Dec 31, 2022 | 369,000.00 |